![West Cancer Center](http://media.vumedi.com/thumbs/channel_logo/2022/6/5cbd97c9-2952-4280-8876-9b418a7d084c.jpeg.200x0_q85.jpg)
West Cancer Center
2020 ASCO Update on SCLC: Anti-PD-1/L1 Staple for 1st L Treatment (Atezolizumab and Durvalumab + EP Improve OS, Pembro Improve PFS) & Safety, Tolerability and Efficacy of Liposomal Irinotecan in 2nd L Setting
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Jason Porter
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Jason Porter
Login to view comments.
Click here to Login
Videos